ALKS Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
496.0M
+26.2%
392.9M
+2.2%
384.5M
-2.4%
394.2M
+0.9%
390.7M
Cost of Revenue
98.1M
+59.3%
61.6M
+33.3%
46.2M
-10.4%
51.6M
+4.3%
49.5M
Gross Profit
397.9M
+20.1%
331.3M
-2.1%
338.3M
-1.2%
342.6M
+0.4%
341.2M
Operating Expenses
379.5M
-0.0%
379.6M
+35.5%
280.2M
+10.5%
253.5M
+2.1%
248.2M
R&D
112.9M
+9.3%
103.3M
+11.1%
93.0M
+13.8%
81.7M
+5.6%
77.4M
SG&A
217.6M
-17.8%
264.6M
+41.3%
187.2M
+9.0%
171.8M
+0.5%
170.8M
Operating Income
18.4M
+138.0%
-48280000
-183.1%
58.1M
-34.8%
89.1M
-4.2%
93.0M
EBITDA
75.0M
+360.1%
-28851000
-146.6%
62.0M
-36.2%
97.2M
-3.6%
100.8M
Net Income
501.0K
+100.8%
-66480000
-234.7%
49.3M
-40.4%
82.8M
-5.0%
87.1M
EPS (Basic)
$0.00
+100.0%
$-0.40
-233.3%
$0.30
-40.0%
$0.50
-5.7%
$0.53
EPS (Diluted)
$0.00
+100.0%
$-0.40
-237.9%
$0.29
-40.8%
$0.49
-5.8%
$0.52
Shares (Diluted)
173.5M
+4.4%
166.2M
-1.9%
169.4M
+0.5%
168.5M
+0.1%
168.4M
Alkermes (ALKS) โ€” Financials